[시장보고서]세계의 RNA 표적 저분자 Drug Discovery 시장 - 산업 규모, 점유율, 동향, 기회, 예측, 적응증별, 최종 사용자별, 지역별, 경쟁별(2020-2030년)

세계의 RNA 표적 저분자 Drug Discovery 시장 - 산업 규모, 점유율, 동향, 기회, 예측, 적응증별, 최종 사용자별, 지역별, 경쟁별(2020-2030년)

RNA Targeting Small Molecule Drug Discovery Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Indication, By End Users, By Region and Competition, 2020-2030F

상품코드 : 1732889

리서치사 : TechSci Research

발행일 : 2025년 05월

페이지 정보 : 영문 188 Pages

라이선스 & 가격 (부가세 별도)

US $ 4,500

￦ 6,497,000

Unprintable PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.

US $ 5,500

￦ 7,940,000

PDF and Excel (Multi-User License)

PDF 및 Excel 보고서를 기업의 팀이나 기관에서 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 및 Excel 이용 범위와 동일합니다.

US $ 8,000

￦ 11,550,000

PDF and Excel (Custom Research License)

PDF 및 Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 및 Excel 이용 범위와 동일합니다. 80시간의 애널리스트 타임이 포함되어 있고 Copy & Paste 가능한 PPT 버전도 제공됩니다. 짧은 Bespoke 리서치 프로젝트 수행에 맞는 라이선스입니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

세계 RNA 표적 저분자 Drug Discovery 시장은 2024년에 16억 8,000만 달러로 평가되었으며, 2030년에는 55억 2,000만 달러에 달할 것으로 예상되며, CAGR 21.93%로 성장할 것으로 예측됩니다.

이 성장의 원동력은 암, 신경질환, 유전성 질환 등 폭넓은 질환에 대응 가능한 RNA 표적 저분자 Drug Discovery에 대한 수요 증가에 힘입은 것입니다.

시장 개요
예측 기간	2026-2030년
시장 규모 : 2024년	16억 8,000만 달러
시장 규모 : 2030년	55억 2,000만 달러
CAGR : 2025-2030년	21.93%
급성장 부문	암
최대 시장	북미

시장 성장 촉진요인

RNA 생물학과 창약 기술의 진보

주요 시장 과제

RNA 구조의 복잡성과 표적 특이성

주요 시장 동향

신약에서 인공지능의 통합

시장 규모와 예측
- 금액별
시장 점유율 및 예측
- 적응증별(암, 감염증, 대사성 질환, 신경 질환, 기타)
- 최종사용자별(제약 및 바이오의약품기업, 학술연구기관, 기타)
- 지역별(북미, 유럽, 아시아태평양, 남미, 중동 및 아프리카)
- 기업별(2024년)
시장 맵
적응증별
최종 사용자별
지역별

제6장 북미의 RNA 표적 저분자 Drug Discovery 시장 전망

시장 규모와 예측
시장 점유율 및 예측
북미 : 국가별 분석
- 미국
- 캐나다
- 멕시코

제7장 유럽의 RNA 표적 저분자 Drug Discovery 시장 전망

시장 규모와 예측
시장 점유율 및 예측
유럽 : 국가별 분석
- 프랑스
- 독일
- 영국
- 이탈리아
- 스페인

제8장 아시아태평양의 RNA 표적 저분자 Drug Discovery 시장 전망

시장 규모와 예측
시장 점유율 및 예측
아시아태평양 : 국가별 분석
- 중국
- 인도
- 일본
- 한국
- 호주

제9장 남미의 RNA 표적 저분자 Drug Discovery 시장 전망

시장 규모와 예측
시장 점유율 및 예측
남미 : 국가별 분석
- 브라질
- 아르헨티나
- 콜롬비아

제10장 중동 및 아프리카의 RNA 표적 저분자 Drug Discovery 시장 전망

시장 규모와 예측
시장 점유율 및 예측
중동 및 아프리카 : 국가별 분석
- 남아프리카
- 사우디아라비아
- 아랍에미리트(UAE)

제11장 시장 역학

성장 촉진요인
과제

제12장 시장 동향과 발전

최근 동향
합병과 인수
제품 출시

제13장 세계의 RNA 표적 저분자 Drug Discovery 시장 : SWOT 분석

제14장 Porter's Five Forces 분석

업계 내 경쟁
신규 진입의 가능성
공급자의 힘
고객의 힘
대체품의 위협

제15장 경쟁 구도

Accent Therapeutics, Inc.
Anima Biotech Inc.
Arrakis Therapeutics, Inc.
AstraZeneca Plc
Epics Therapeutics, Inc.
Expansion Therapeutics, Inc.
F.Hoffmann-La Roche AG
H3 Biomedicine Inc.
PTC Therapeutics, Inc.
Ribometrix, Inc.

제16장 전략적 제안

제17장 기업 소개와 면책사항

SHW

영문 목차

영문목차

The Global RNA Targeting Small Molecule Drug Discovery Market, valued at USD 1.68 billion in 2024, is projected to reach USD 5.52 billion by 2030, growing at a CAGR of 21.93%. This growth is fueled by the increasing demand for RNA-targeted small molecule drugs capable of addressing a wide range of conditions, including cancer, neurological, and genetic disorders. Innovations in RNA-targeted drug discovery methods and heightened government support for RNA research are accelerating development in this field, attracting significant investments and interest across the pharmaceutical industry.

Market Overview
Forecast Period	2026-2030
Market Size 2024	USD 1.68 Billion
Market Size 2030	USD 5.52 Billion
CAGR 2025-2030	21.93%
Fastest Growing Segment	Cancer
Largest Market	North America

Key Market Drivers

Advancements in RNA Biology and Drug Discovery Technologies

Recent developments in RNA biology have revealed new RNA structures and functionalities as viable therapeutic targets. Tools like high-throughput sequencing and gene editing have significantly advanced the discovery of novel RNA targets and the creation of small molecules that can regulate RNA activity. These technological strides are streamlining drug development, making therapies more precise and effective. Moreover, the integration of computational methods and artificial intelligence is improving the prediction of RNA structures and interactions, thereby enhancing the efficiency of the discovery process. These advancements are driving increased pharmaceutical investment in RNA-targeted therapy.

Key Market Challenges

Complexity of RNA Structures and Target Specificity

Designing small molecules to selectively bind RNA targets is inherently challenging due to the intricate secondary and tertiary structures of RNA molecules. Precision is vital to prevent unintended interactions with non-target RNAs, which could cause adverse effects. The flexible nature of RNA adds another layer of difficulty in identifying stable and effective binding sites. Overcoming these hurdles necessitates sophisticated structural analysis tools and innovative drug development strategies, which demand substantial time and resources.

Key Market Trends

Integration of Artificial Intelligence in Drug Discovery

Artificial Intelligence (AI) is playing a transformative role in the discovery of RNA-targeted small molecules. AI technologies are capable of analyzing large datasets to forecast RNA structures, locate potential binding regions, and simulate molecular behavior, which greatly accelerates candidate identification. This not only improves the precision and efficiency of development but also cuts down the time and expense compared to traditional methods. As AI tools continue to evolve, their contribution to RNA-based therapeutic discovery is expected to grow, paving new pathways for drug development.

Key Market Players

Accent Therapeutics, Inc.
Anima Biotech Inc.
Arrakis Therapeutics, Inc.
AstraZeneca Plc
Epics Therapeutics, Inc.
Expansion Therapeutics, Inc.
F. Hoffmann-La Roche AG
H3 Biomedicine Inc.
PTC Therapeutics, Inc.
Ribometrix, Inc.

Report Scope:

In this report, Global RNA Targeting Small Molecule Drug Discovery market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

RNA Targeting Small Molecule Drug Discovery Market, By Indication:

Cancer
Infectious Diseases
Metabolic Diseases
Neurological Diseases
Other

RNA Targeting Small Molecule Drug Discovery Market, By End Users:

Pharmaceutical and Biopharmaceutical Companies
Academic and Research Institutes
Others

RNA Targeting Small Molecule Drug Discovery Market, By Region:

North America
- United States
- Canada
- Mexico
Europe
- France
- Germany
- United Kingdom
- Italy
- Spain
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
South America
- Brazil
- Argentina
- Colombia
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global RNA Targeting Small Molecule Drug Discovery Market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global RNA Targeting Small Molecule Drug Discovery Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By Indication (Cancer, Infectious Diseases, Metabolic Diseases, Neurological Diseases, Others)
- 5.2.2. By End Users (Pharmaceutical and Biopharmaceutical Companies, Academic and Research Institutes, Others)
- 5.2.3. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
- 5.2.4. By Company (2024)
5.3. Market Map
5.3.1 By Indication
5.3.2 By End Users
5.3.3 By Region

6. North America RNA Targeting Small Molecule Drug Discovery Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Indication (Cancer, Infectious Diseases, Metabolic Diseases, Neurological Diseases, Others)
- 6.2.2. By End Users (Pharmaceutical and Biopharmaceutical Companies, Academic and Research Institutes, Others)
- 6.2.3. By Country
6.3. North America: Country Analysis
- 6.3.1. United States RNA Targeting Small Molecule Drug Discovery Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By Indication
    - 6.3.1.2.2. By End User
- 6.3.2. Canada RNA Targeting Small Molecule Drug Discovery Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By Indication
    - 6.3.2.2.2. By End User
- 6.3.3. Mexico RNA Targeting Small Molecule Drug Discovery Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By Indication
    - 6.3.3.2.2. By End User

7. Europe RNA Targeting Small Molecule Drug Discovery Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Indication (Cancer, Infectious Diseases, Metabolic Diseases, Neurological Diseases, Others)
- 7.2.2. By End Users (Pharmaceutical and Biopharmaceutical Companies, Academic and Research Institutes, Others)
- 7.2.3. By Country
7.3. Europe: Country Analysis
- 7.3.1. France RNA Targeting Small Molecule Drug Discovery Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Indication
    - 7.3.1.2.2. By End User
- 7.3.2. Germany RNA Targeting Small Molecule Drug Discovery Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Indication
    - 7.3.2.2.2. By End User
- 7.3.3. United Kingdom RNA Targeting Small Molecule Drug Discovery Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecast
    - 7.3.3.2.1. By Indication
    - 7.3.3.2.2. By End User
- 7.3.4. Italy RNA Targeting Small Molecule Drug Discovery Market Outlook
  - 7.3.4.1. Market Size & Forecast
    - 7.3.4.1.1. By Value
  - 7.3.4.2. Market Share & Forecast
    - 7.3.4.2.1. By Indication
    - 7.3.4.2.2. By End User
- 7.3.5. Spain RNA Targeting Small Molecule Drug Discovery Market Outlook
  - 7.3.5.1. Market Size & Forecast
    - 7.3.5.1.1. By Value
  - 7.3.5.2. Market Share & Forecast
    - 7.3.5.2.1. By Indication
    - 7.3.5.2.2. By End User

8. Asia-Pacific RNA Targeting Small Molecule Drug Discovery Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Indication (Cancer, Infectious Diseases, Metabolic Diseases, Neurological Diseases, Others)
- 8.2.2. By End Users (Pharmaceutical and Biopharmaceutical Companies, Academic and Research Institutes, Others)
- 8.2.3. By Country
8.3. Asia-Pacific: Country Analysis
- 8.3.1. China RNA Targeting Small Molecule Drug Discovery Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Indication
    - 8.3.1.2.2. By End User
- 8.3.2. India RNA Targeting Small Molecule Drug Discovery Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Indication
    - 8.3.2.2.2. By End User
- 8.3.3. Japan RNA Targeting Small Molecule Drug Discovery Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Indication
    - 8.3.3.2.2. By End User
- 8.3.4. South Korea RNA Targeting Small Molecule Drug Discovery Market Outlook
  - 8.3.4.1. Market Size & Forecast
    - 8.3.4.1.1. By Value
  - 8.3.4.2. Market Share & Forecast
    - 8.3.4.2.1. By Indication
    - 8.3.4.2.2. By End User
- 8.3.5. Australia RNA Targeting Small Molecule Drug Discovery Market Outlook
  - 8.3.5.1. Market Size & Forecast
    - 8.3.5.1.1. By Value
  - 8.3.5.2. Market Share & Forecast
    - 8.3.5.2.1. By Indication
    - 8.3.5.2.2. By End User

9. South America RNA Targeting Small Molecule Drug Discovery Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Indication (Cancer, Infectious Diseases, Metabolic Diseases, Neurological Diseases, Others)
- 9.2.2. By End Users (Pharmaceutical and Biopharmaceutical Companies, Academic and Research Institutes, Others)
- 9.2.3. By Country
9.3. South America: Country Analysis
- 9.3.1. Brazil RNA Targeting Small Molecule Drug Discovery Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Indication
    - 9.3.1.2.2. By End User
- 9.3.2. Argentina RNA Targeting Small Molecule Drug Discovery Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Indication
    - 9.3.2.2.2. By End User
- 9.3.3. Colombia RNA Targeting Small Molecule Drug Discovery Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Indication
    - 9.3.3.2.2. By End User

10. Middle East and Africa RNA Targeting Small Molecule Drug Discovery Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Indication (Cancer, Infectious Diseases, Metabolic Diseases, Neurological Diseases, Others)
- 10.2.2. By End Users (Pharmaceutical and Biopharmaceutical Companies, Academic and Research Institutes, Others)
- 10.2.3. By Country
10.3. MEA: Country Analysis
- 10.3.1. South Africa RNA Targeting Small Molecule Drug Discovery Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Indication
    - 10.3.1.2.2. By End User
- 10.3.2. Saudi Arabia RNA Targeting Small Molecule Drug Discovery Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Indication
    - 10.3.2.2.2. By End User
- 10.3.3. UAE RNA Targeting Small Molecule Drug Discovery Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Indication
    - 10.3.3.2.2. By End User

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Recent Development
12.2. Mergers & Acquisitions
12.3. Product Launches

13. Global RNA Targeting Small Molecule Drug Discovery Market: SWOT Analysis

14. Porter's Five Forces Analysis

14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products

15. Competitive Landscape

15.1. Accent Therapeutics, Inc.
- 15.1.1. Business Overview
- 15.1.2. Company Snapshot
- 15.1.3. Products & Services
- 15.1.4. Financials (As Reported)
- 15.1.5. Recent Developments
- 15.1.6. Key Personnel Details
- 15.1.7. SWOT Analysis
15.2. Anima Biotech Inc.
15.3. Arrakis Therapeutics, Inc.
15.4. AstraZeneca Plc
15.5. Epics Therapeutics, Inc.
15.6. Expansion Therapeutics, Inc.
15.7. F.Hoffmann-La Roche AG
15.8. H3 Biomedicine Inc.
15.9. PTC Therapeutics, Inc.
15.10. Ribometrix, Inc.